## SWK: Stanley Black & Decker, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 1.1% below STRENGTH zone (3.0-6.0%); PEG 1.37 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($71.27)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bearish (Bullish: 0, Bearish: 1)

**1. Stanley Black & Decker, Inc. $SWK Shares Acquired by Fort Washington Investment Advisors Inc. OH**
- Source: MarketBeat | 20251230T120036 | Neutral | Relevance: 100%
- Fort Washington Investment Advisors Inc. OH increased its stake in Stanley Black & Decker (NYSE:SWK) by 1.0% in Q3, purchasing 15,349 shares to own a total of 1,553,709 shares valued at approximately $115.49 million. The industrial products company offers a quarterly dividend of $0.83, translating to an annualized dividend of $3.32 and a 4.4% yield, despite a high payout ratio of 114.88%. Analysts currently hold a consensus "Hold" rating for SWK with an average price target of $87.33.

**2. DoJ Says Stanley Black & Decker Delayed Reporting of Hazardous Products**
- Source: Modern Distribution Management | 20251229T180827 | Bearish | Relevance: 100%
- The U.S. Justice Department has filed a civil complaint against Stanley Black & Decker, alleging the company failed to promptly report safety hazards related to certain DeWALT utility bars and miter saws to federal regulators. The complaint, filed jointly with the U.S. Consumer Product Safety Commission, seeks civil penalties and injunctive relief. It highlights alleged delays in reporting issues that led to injuries, underscoring the critical nature of timely product safety reporting to protect consumers.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | Baird | $85 | $75 | +13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | Baird | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 10 ($0.07M) |
| Sells | 5 ($1.07M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (-2.3%)
- Capital Research Glo: 8.2% (+0.9%)
- Blackrock Inc.: 6.7% (-11.1%)
- Price (T.Rowe) Assoc: 6.3% (-19.4%)
- State Street Corpora: 5.6% (-7.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- New product launch cycle could drive revenue acceleration.
- Momentum building: MRS_10 improving +1.8% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.37 suggests fair value with growth premium. Forward P/E 13.0x attractive for 27% earnings growth. Analyst sentiment positive (1 raises, avg +13%). Insider selling cluster ($1.1M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.6B |
| Beta | 1.20 |
| 52W Range | $53.91 - $91.06 |
| Short Interest | 4.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.37 |
| Forward P/E | 13.0 |
| Current P/E | 16.5 |
| YoY Growth | 27.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.7% to 1.1% (+1.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.9pp (needs >3.0% for momentum thesis). MRS_5 at 0.7% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 60. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.07% (CS: 84) | Neutral |
| RSI_14 | 59.9 | Neutral |
| MACD Histogram | 0.02 | Bullish |
| vs SMA20 | 1.019x | Above |
| vs SMA50 | 1.068x | Above |
| vs SMA200 | 1.074x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $75.19
- **Stop Loss:** $71.27 (5.2% risk)
- **Target:** $79.11 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 336
- **Position Value:** $25,263.84
- **Portfolio %:** 25.26%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-05 (Est: $1.28)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.19 | $1.43 | +20.0% |
| 2025Q2 | $0.42 | $1.08 | +159.7% |
| 2025Q1 | $0.66 | $0.75 | +13.9% |
| 2024Q4 | $1.27 | $1.49 | +17.3% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*